| Catherine Chang, OTR/L | |
|
833 Northern Blvd Suite 235, Great Neck, NY 11021-2105 | |
| (516) 288-3400 | |
| (516) 288-3410 |
| Full Name | Catherine Chang |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 8 Years |
| Location | 833 Northern Blvd Suite 235, Great Neck, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033563697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 020389-1 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sports Physical Therapy Occupational Therapy And Rehabilitation Servic | 0446140446 | 374 |
News Archive
Today, GE Healthcare Medical Diagnostics announced results of a study that evaluated the cardiopulmonary safety of Optison- (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in improving suboptimal echocardiograms.
A new class of cancer drugs just now entering the marketplace seems promising so far, but researchers at the University of Illinois at Chicago urge doctors to take into account a patient's weight and liver status before prescribing them once they come on the market.
Guided Therapeutics, Inc., developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it has begun human testing of its light-based detection technology for Barrett's Esophagus, a precursor for esophageal cancer. The technology is being jointly developed with Konica Minolta Opto of Japan.
An experimental procedure that dramatically strengthens stem cells' ability to regenerate damaged tissue could offer new hope to sufferers of muscle-wasting diseases such as myopathy and muscular dystrophy, according to researchers from the University of New South Wales (UNSW).
British scientists have found that cholesterol levels in healthy adults can be raised by stress.
› Verified 2 days ago
| Provider Name | Sports Physical Therapy Occupational Therapy And Rehabilitation Servic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770540593 PECOS PAC ID: 0446140446 Enrollment ID: O20040315001603 |
News Archive
Today, GE Healthcare Medical Diagnostics announced results of a study that evaluated the cardiopulmonary safety of Optison- (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in improving suboptimal echocardiograms.
A new class of cancer drugs just now entering the marketplace seems promising so far, but researchers at the University of Illinois at Chicago urge doctors to take into account a patient's weight and liver status before prescribing them once they come on the market.
Guided Therapeutics, Inc., developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it has begun human testing of its light-based detection technology for Barrett's Esophagus, a precursor for esophageal cancer. The technology is being jointly developed with Konica Minolta Opto of Japan.
An experimental procedure that dramatically strengthens stem cells' ability to regenerate damaged tissue could offer new hope to sufferers of muscle-wasting diseases such as myopathy and muscular dystrophy, according to researchers from the University of New South Wales (UNSW).
British scientists have found that cholesterol levels in healthy adults can be raised by stress.
› Verified 2 days ago
| Provider Name | Metro Physical Occupational And Speech Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1356742365 PECOS PAC ID: 1254553639 Enrollment ID: O20141120000039 |
News Archive
Today, GE Healthcare Medical Diagnostics announced results of a study that evaluated the cardiopulmonary safety of Optison- (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in improving suboptimal echocardiograms.
A new class of cancer drugs just now entering the marketplace seems promising so far, but researchers at the University of Illinois at Chicago urge doctors to take into account a patient's weight and liver status before prescribing them once they come on the market.
Guided Therapeutics, Inc., developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it has begun human testing of its light-based detection technology for Barrett's Esophagus, a precursor for esophageal cancer. The technology is being jointly developed with Konica Minolta Opto of Japan.
An experimental procedure that dramatically strengthens stem cells' ability to regenerate damaged tissue could offer new hope to sufferers of muscle-wasting diseases such as myopathy and muscular dystrophy, according to researchers from the University of New South Wales (UNSW).
British scientists have found that cholesterol levels in healthy adults can be raised by stress.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Catherine Chang, OTR/L 72-35 112th St, Forest Hills, NY 11375 Ph: (516) 941-7555 | Catherine Chang, OTR/L 833 Northern Blvd Suite 235, Great Neck, NY 11021-2105 Ph: (516) 288-3400 |
News Archive
Today, GE Healthcare Medical Diagnostics announced results of a study that evaluated the cardiopulmonary safety of Optison- (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in improving suboptimal echocardiograms.
A new class of cancer drugs just now entering the marketplace seems promising so far, but researchers at the University of Illinois at Chicago urge doctors to take into account a patient's weight and liver status before prescribing them once they come on the market.
Guided Therapeutics, Inc., developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it has begun human testing of its light-based detection technology for Barrett's Esophagus, a precursor for esophageal cancer. The technology is being jointly developed with Konica Minolta Opto of Japan.
An experimental procedure that dramatically strengthens stem cells' ability to regenerate damaged tissue could offer new hope to sufferers of muscle-wasting diseases such as myopathy and muscular dystrophy, according to researchers from the University of New South Wales (UNSW).
British scientists have found that cholesterol levels in healthy adults can be raised by stress.
› Verified 2 days ago
Mark Guzman, OTR/L Occupational Therapist Medicare: May Accept Medicare Assignments Practice Location: 475 Northern Blvd Ste 19, Great Neck, NY 11021 Phone: 516-829-0030 | |
Madeline E Sieber, Occupational Therapist Medicare: May Accept Medicare Assignments Practice Location: 475 Northern Blvd Ste 19, Great Neck, NY 11021 Phone: 516-829-0030 Fax: 516-466-7723 | |
Grace Lisandrelli, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 475 Northern Blvd Ste 19, Great Neck, NY 11021 Phone: 516-829-0030 | |
Katherine Susan Bowles, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 475 Northern Blvd, Great Neck, NY 11021 Phone: 516-829-0030 | |
Regina Kakuriyeva, OTR/L Occupational Therapist Medicare: May Accept Medicare Assignments Practice Location: 475 Northern Blvd Ste 19, Great Neck, NY 11021 Phone: 516-829-0030 Fax: 516-466-7723 | |
Rachel Ahdoot, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 20 Fir Dr, Great Neck, NY 11024 Phone: 516-225-8905 |